EP Patent

EP0420964A1 — Lyophilized peptide formulations

Assigned to Immunobiology Research Institute Inc · Expires 1991-04-10 · 35y expired

What this patent protects

The invention relates to a method for stabilizing lyophilized clinical quantities of pharmacologically advantageous peptides.

USPTO Abstract

The invention relates to a method for stabilizing lyophilized clinical quantities of pharmacologically advantageous peptides.

Drugs covered by this patent

Patent Metadata

Patent number
EP0420964A1
Jurisdiction
EP
Classification
—
Expires
1991-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Immunobiology Research Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.